Showing 2641-2650 of 23150 results for "".
Is Friedreich’s Ataxia Developmental or Degenerative?
https://reachmd.com/programs/neurofrontiers/friedreichs-ataxia-developmental-or-degenerative/54671/Friedreich’s ataxia may begin as a developmental disorder driven by in utero frataxin deficiency, rather than a purely neurodegenerative condition. This evolving perspective has important implications for early diagnosis and treatment timing. In this episode, hear Dr. Arnie Koeppen explore how redefConquering the Burden & Impacts of PNH
https://reachmd.com/programs/project-oncology/conquering-the-burden-impacts-of-pnh/48878/What strategies or resources are available for clinicians to use to help their patients overcome the PNH burden? Tune in.Why Words Matter: Rethinking Terminology in Advanced Prostate Cancer
https://reachmd.com/programs/frontlines-prostate-cancer/why-words-matter-rethinking-terminology-in-advanced-prostate-cancer/32222/Inconsistent or stigmatizing terminology like “castration-resistant prostate cancer” can hinder both clinical clarity and patient acceptance of life-prolonging therapies, underscoring the importance of utilizing more accurate, sensitive terms like “androgen deprivation resistant prostate cancer.” HeClimate Change and Skin Health: Challenges and Adaptive Strategies
https://reachmd.com/programs/medical-industry-feature/climate-change-and-skin-health-challenges-and-adaptive-strategies/32932/Discover how heat, pollution, and UV damage can affect skin health, and explore strategies to mitigate these impacts.Antiphospholipid Syndrome: Unraveling a Complex Autoimmune Disorder
https://reachmd.com/programs/living-rheum/antiphospholipid-syndrome-unraveling-a-complex-autoimmune-disorder/24326/Antiphospholipid Syndrome is a challenging and complex autoimmune condition characterized by abnormal blood clotting. Here's the latest on current treatments and research.Detecting MS Biomarkers: An IgG Antibody Blood Test Offers 90% Accuracy
https://reachmd.com/programs/neurofrontiers/detecting-ms-biomarkers-an-igg-antibody-blood-test-offers-90-accuracy/16252/Dive into the findings and potential impacts of a recent study that evaluated an IgG antibody blood test’s ability to identify MS biomarkers.Key Considerations for CGM Use in Older Adults with T1D
https://reachmd.com/programs/diabetes-discourse/key-considerations-for-cgm-use-in-older-adults-with-t1d/15156/Get the latest insights on how continuous glucose monitoring can affect older adults with type 1 diabetes.A Patient's Journey with ADPKD
https://reachmd.com/programs/advances-chronic-kidney-disease/a-patients-journey-with-adpkd/14827/There’s a lot to consider when it comes to the management of autosomal dominant polycystic kidney disease (ADPKD). But how often do we think about this genetic disorder from the perspective of the very patients we’re treating? Here to share her perspective as a patient living with ADPKD is EirenA Debate on Dosing Considerations: Perspectives on Antimicrobials
https://reachmd.com/programs/idsa-action-center/a-debate-on-dosing-considerations-perspectives-on-antimicrobials/14231/How can clinicians optimize antimicrobial dosing to improve care for there patients? Find out.Conversations Around Chemotherapy: Do All of Your Patients Need It?
https://reachmd.com/programs/project-oncology/conversations-around-chemotherapy-do-all-of-your-patients-need-it/13665/Chemotherapy is commonly used to combat cancer—but do all of your patients really need it?